{"id":920988,"date":"2025-12-18T09:37:28","date_gmt":"2025-12-18T14:37:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/"},"modified":"2025-12-18T09:37:28","modified_gmt":"2025-12-18T14:37:28","slug":"gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/","title":{"rendered":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance<\/b><\/p>\n<p>FOSTER CITY, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General Counsel, Legal &amp; Compliance effective immediately. She will join the company\u2019s senior leadership team and report to Chairman and Chief Executive Officer Daniel O\u2019Day.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg\" alt=\"Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance\" \/><\/p>\n<p style=\"font-size:85%\">Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance<\/p>\n<\/div>\n<p>\nMs. Wettan has held increasingly senior legal leadership roles within Gilead during her 14-year tenure, most recently as Senior Vice President leading the Global Legal Business Partners team. She previously led the Litigation and Government Investigations and the Corporate Governance and Strategic Transactions teams. Ms. Wettan has been instrumental in supporting the launch of groundbreaking medicines, including the recent launch of lenacapavir, a breakthrough twice-yearly HIV prevention medicine. She also currently serves as the Chair of the Board of the Gilead Foundation.\n<\/p>\n<p>\n\u201cKeeley is an accomplished executive who brings deep legal expertise, and who leads with integrity, passion and commitment to the people and communities we serve,\u201d said Daniel O\u2019Day, Chairman and Chief Executive Officer, Gilead Sciences. \u201cDuring her 14-year career with Gilead, Keeley has helped to drive some of our most important progress from the launch of groundbreaking new medicines to pioneering access agreements. I am confident that Keeley will be an excellent addition to the Gilead Leadership Team as we continue to deliver on the strongest pipeline in our history.\u201d\n<\/p>\n<p>\nPrior to joining Gilead, Keeley was an attorney at the law firm Simpson Thacher &amp; Bartlett in New York City where her practice focused on general litigation and government investigations. Keeley received her J.D. from the University of California at Berkeley.\n<\/p>\n<p><b><span class=\"bwuline\">About Gilead Sciences<\/span><\/b><\/p>\n<p>\nGilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness \u2013 while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.\n<\/p>\n<p class=\"bwalignc\"><i>For more information about Gilead, please visit the company\u2019s website at <\/i><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gilead.com&amp;esheet=54379858&amp;newsitemid=20251218926462&amp;lan=en-US&amp;anchor=www.gilead.com&amp;index=1&amp;md5=4ea39cd5794e991c06936dcd4e01b865\"><i>www.gilead.com<\/i><\/a><i>, follow Gilead on X\/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218926462r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/<\/a><\/span><\/p>\n<p>\nAshleigh Koss, Media<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:public_affairs@gilead.com\">public_affairs@gilead.com<\/a><\/p>\n<p>\nJacquie Ross, Investors<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investor_relations@gilead.com\">investor_relations@gilead.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology AIDS Hospitals Health Pharmaceutical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/3\/Keeley_Wettan_0021.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/778437\/3\/GCP_Primarylarge_1.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General Counsel, Legal &amp; Compliance effective immediately. She will join the company\u2019s senior leadership team and report to Chairman and Chief Executive Officer Daniel O\u2019Day. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/ Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance Ms. Wettan has held increasingly senior legal leadership roles within Gilead during her 14-year tenure, most recently as Senior Vice President leading the Global Legal Business Partners team. She previously led the Litigation and Government Investigations &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-920988","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General Counsel, Legal &amp; Compliance effective immediately. She will join the company\u2019s senior leadership team and report to Chairman and Chief Executive Officer Daniel O\u2019Day. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/ Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance Ms. Wettan has held increasingly senior legal leadership roles within Gilead during her 14-year tenure, most recently as Senior Vice President leading the Global Legal Business Partners team. She previously led the Litigation and Government Investigations &hellip; Continue reading &quot;Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-18T14:37:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance\",\"datePublished\":\"2025-12-18T14:37:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/\"},\"wordCount\":516,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251218926462\\\/en\\\/2674279\\\/4\\\/Keeley_Wettan_0021.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/\",\"name\":\"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251218926462\\\/en\\\/2674279\\\/4\\\/Keeley_Wettan_0021.jpg\",\"datePublished\":\"2025-12-18T14:37:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251218926462\\\/en\\\/2674279\\\/4\\\/Keeley_Wettan_0021.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251218926462\\\/en\\\/2674279\\\/4\\\/Keeley_Wettan_0021.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/","og_locale":"en_US","og_type":"article","og_title":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance - Market Newsdesk","og_description":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211; Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General Counsel, Legal &amp; Compliance effective immediately. She will join the company\u2019s senior leadership team and report to Chairman and Chief Executive Officer Daniel O\u2019Day. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251218926462\/en\/ Gilead Sciences appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance Ms. Wettan has held increasingly senior legal leadership roles within Gilead during her 14-year tenure, most recently as Senior Vice President leading the Global Legal Business Partners team. She previously led the Litigation and Government Investigations &hellip; Continue reading \"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-18T14:37:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance","datePublished":"2025-12-18T14:37:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/"},"wordCount":516,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/","name":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg","datePublished":"2025-12-18T14:37:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251218926462\/en\/2674279\/4\/Keeley_Wettan_0021.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gilead-sciences-appoints-keeley-wettan-as-executive-vice-president-general-counsel-legal-compliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal &amp; Compliance"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/920988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=920988"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/920988\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=920988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=920988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=920988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}